Escherichia coli accumulates malto-oligosaccharides by the maltose transport system, which is a member of the ATP-binding-cassette (ABC) superfamily of transport systems. The proteins of this system are LamB in the outer membrane, maltose-binding protein (MBP) in the periplasm, and the proteins of the inner membrane complex (MalFGK 2 ), composed of one MalF, one MalG, and two MalK subunits. Substrate specificity is determined primarily by the periplasmic component, MBP. However, several studies of the maltose transport system as well as other members of the ABC transporter superfamily have suggested that the integral inner membrane components MalF and MalG may play an important role in determining the specificity of the system. We show here that residue L334 in the fifth transmembrane helix of MalF plays an important role in determining the substrate specificity of the system. A leucine-to-tryptophan alteration at this position (L334W) results in the ability to transport lactose in a saturable manner. This mutant requires functional MalK-ATPase activity and the presence of MBP, even though MBP is incapable of binding lactose. The requirement for MBP confirms that unliganded MBP interacts with the inner membrane MalFGK 2 complex and that MBP plays a crucial role in triggering the transport process.
The maltose transport system of Escherichia coli mediates the unidirectional transport of ␣(1-4)-linked malto-oligosaccharides (up to maltoheptaose) from the extracellular medium into the cytoplasm of the cell (14) . It is a member of the ATP-binding-cassette (ABC) superfamily of transport systems (2) by virtue of its strong sequence homology and similar domain structure. Members of this family are found in a variety of organisms and include the cystic fibrosis transmembrane conductance regulator in humans as well as the STE6 protein of Saccharomyces cerevisiae (24) . The maltose transport system is composed of five proteins: LamB (maltoporin), maltosebinding protein (MBP), MalF, MalG, and MalK (44) . The genes that encode these proteins are located in divergent operons in the malB region of the E. coli chromosome.
The LamB protein is an outer membrane porin that facilitates the diffusion of malto-oligosaccharides into the periplasm of the cell (39, 47) . LamB also functions as the receptor for phage (36) . MBP is a soluble periplasmic protein that binds malto-oligosaccharides with a high affinity (K d ϭ 0.1 to 1 M) (15, 28, 40) . MBP is thought to deliver the substrate to the inner membrane complex, and it is required for the transport of maltose (41, 50) . The three-dimensional structure of MBP has been determined to the atomic level by X-ray crystallography (46) . The subunit stoichiometry of the inner membrane MalF-MalG-MalK complex is 1:1:2 (MalFGK 2 ) (9). This complex transports the substrate across the inner membrane in an ATP-dependent manner. The MalF and MalG proteins are integral membrane proteins that are predicted to traverse the membrane eight and six times, respectively (3, 8, 16) . MalK is a peripheral protein associated with the inner membrane probably through interactions with the MalF and MalG proteins (34, 43) . MalK binds and hydrolyzes ATP (34, 51) and has strong sequence homology with the ATP-binding domains of other ABC transporters (23) .
Although substrate binding by the periplasmic component (MBP) has been well-documented by several approaches (15, (19) (20) (21) (22) 46) , very little is known about how the inner membrane complex recognizes malto-oligosaccharides. MBP binds a substrate with a K d that reflects the K m of transport, and it is regarded as the main determinant of substrate specificity for the maltose system. However, mutants of MalF and MalG that transport maltose in the absence of MBP (MBP-independent mutants) have been isolated (50) . These mutants retain substrate specificity for malto-oligosaccharides. This result suggests that MalF and MalG play an important role in the recognition of malto-oligosaccharides. The MBP-independent mutants exhibit a K m for maltose transport of approximately 2 mM, but they each display a V max that varies from the wild-type values to values approximately 20-fold lower. Thus, all of the mutant transporters may bind maltose equally well, which is suggestive of similar substrate binding sites, but they translocate with different efficiencies.
The recent characterization of transmembrane domains 6, 7, and 8 of MalF by mutational analysis has implicated these domains as playing a role in the recognition of the substrate (13) . The various mutations led to phenotypes where the ranges of substrates transported by the system were different. While the wild-type system recognizes maltose and longer maltodextrins, the mutants could recognize only one or the other. The clustering of mutations suggests that these transmembrane helices line the substrate path, and suppressor analysis suggests interaction among the helices of MalF.
Biochemical and genetic analyses of other members of the ABC transporter superfamily, most notably P-glycoprotein (Pgp) and HlyB transporter, have also implicated the transmembrane domains as playing a crucial role in determining substrate specificity (5, 18, 22, 37, 52) .
The functional exchangeability of the ABC components of the Ugp and Mal transport systems without any loss of substrate specificity suggests that this component does not play a role in determining the overall specificity of the system (23). The Ugp transport system of E. coli transports sn-glycerol-3-phosphate and is a member of the ABC superfamily of transport systems. The UgpC and MalK proteins of these systems are highly homologous, and both couple energy via ATP hydrolysis (23) .
Mutants with altered substrate specificities have proven to be informative concerning the lac permease (LacY) of E. coli. Mutants of LacY that acquired the ability to transport maltose were isolated (4, 42) . The locations of these mutations have provided insight into the residues involved in the recognition of substrate by LacY.
In the present study we describe a mutant of the maltose transport system that transports lactose efficiently. The mutant carries a missense mutation in the malF gene that changes leucine to tryptophan at amino acid 334 of MalF. This fact indicates that either residue 334 plays an important role directly in substrate recognition through the inner membrane complex or indirectly by influencing another residue. The isolation and characterization of this mutant with respect to transport efficiency, maltose transport components required, and substrate specificity are described.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains are listed in Table 1 . The recombinationdefective recA1 strain, GM1418, was constructed by P1vir transduction with a lysate prepared from HS3078 containing the srl::Tn10 mutation closely linked to the recA1 allele. Tetracycline-resistant transductants of strain LH1375 were selected and screened for UV sensitivity.
Media and genetic techniques. Rich medium (Luria broth) and minimal medium (M63) were prepared as described previously (30) . Standard genetic techniques were performed by the method of Miller (30) unless otherwise noted. Maltose and lactose were obtained from Pfanstiehl Laboratories, Inc. All other sugars were obtained from Sigma. The following antibiotics were used at the (6) , that overproduces the MalT activator.
Colonies of HS3309 freshly transformed with pLH1 were washed off the selective plate and grown in superbroth (20 g of tryptone, 10 g of yeast extract, 5 g of NaCl/liter) containing 100 g of ampicillin per ml at 37°C overnight. A periplasmic preparation was made as previously described. It was dialyzed twice against 2 liters of 50 mM Tris-HCl (pH 7.5). MBP was purified on a DE-52 (Whatman) ion-exchange column (1.8 cm [diameter] by 12 cm [height]; BioRad). A bed volume of ϳ20 ml is adequate to purify MBP from 1 liter of cell culture. The column was equilibrated with 5 bed volumes of degassed 50 mM Tris-HCl (pH 7.5) at a flow rate of 0.44 ml/min. The periplasmic preparation was loaded onto the column, washed with 2 bed volumes of degassed 50 mM TrisHCl (pH 7.5), and eluted with 25 mM NaCl-50 mM Tris-HCl (pH 7.5)-2 mM dithiothreitol at a flow rate of 0.44 ml/min. Fractions were collected and monitored by absorbance at 280 nm (A 280 ). Protein-positive fractions were further analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Coomassie blue staining. MBP-containing fractions were pooled and dialyzed twice against 2 liters of 50 mM Tris-HCl (pH 7.5). The final preparation contained Ͼ95%-pure MBP as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Coomassie blue staining. The concentration of MBP was estimated by measuring the A 280 . An A 280 value of 1.7 corresponds to an MBP concentration of 1 mg/ml.
Measurement of sugar binding to MBP: intrinsic fluorescence quenching assay. Intrinsic fluorescence measurements of MBP (47) were performed on an AMINCO Sp1500 fluorescence spectrophotometer. The emission spectra from 300 to 500 nm were recorded with an excitation wavelength of 280 nm. The width of the excitation and emission slits was 1.2 nm. The measurements were carried out at room temperature in 50 mM Tris-HCl (pH 7.5) at an MBP concentration of 36 g/ml. Maximum fluorescence emission occurred at 340 nm. Increasing amounts of maltose were added to a maximum concentration of 2.5 mM. Increasing amounts of lactose were added to a maximum concentration of 5 mM. 
RESULTS
Identification of the lactose-specificity mutant. We constructed indicator strains to detect altered-substrate-specificity mutants with alterations in the maltose transport system that transports lactose. The indicator strains have some common attributes. They all have a deletion of the chromosomal lactose operon but carry the lacZ gene on a plasmid or FЈ episome. Thus, these strains can metabolize intracellular lactose but are incapable of transporting it into cells. The strains also carry the malTp 1 Tp 7 allele (6), ensuring a high level of constitutive mal gene expression. Mutations that permit lactose transport therefore result in a Lac ϩ phenotype. Indeed, selection for such mutants yielded only a single colony. The mutation in this strain results in truncation of MalF following codon 98 (unpublished data).
We also examined a collection of previously characterized MBP-independent mutants for their ability to transport lactose. MBP-independent mutants do not require MBP for maltose transport and exhibit high levels of constitutive ATPase activity (7, 10) . We reasoned that some of these mutants might permit the transport of other sugars, including lactose. MBPindependent mutants carry two mutations: one is referred to as the proximal mutation and the other is referred to as the distal mutation on the basis of their relative locations. The single point mutations had been separated from each other for all of the available MBP-independent mutants and placed on separate plasmids (7) . The collection of these plasmids, as well as the collection of plasmids carrying MBP-independent alleles (total of 34), was transformed into the lactose indicator strains GM1265 and GM1191. The transformants were then assayed for the ability to utilize lactose as the sole carbon source, as determined by growth on plates containing minimal medium plus lactose. Only one of these plasmids, pMY14 (7), conferred the ability to transport lactose.
The pMY14 plasmid carries the malF515 allele and a wildtype copy of the malG gene, both of which are under the transcriptional control of the malB promoter. The mutation responsible for the phenotype of this plasmid had previously been determined to be a leucine-to-tryptophan alteration at amino acid 334 of MalF in membrane-spanning segment 5. This mutation in malF is one of two mutations that comprise the MBP-independent allele malF526 (7). The MalF515 mutant does not transport maltose in an MBP-independent manner and does not display constitutive ATPase activity (7) . Thus, contrary to our expectations, neither the ability to carry out MBP-independent transport nor high rates of ATPase activity are required for lactose transport.
Lactose transport via the MalF515 mutant requires MBP. To find out if any of the other components of the wild-type maltose transport system were required for maltose transport by the specificity mutant, we compared its phenotypes in both wild-type (GM1265) and ⌬malB101 deletion (GM1191) strain backgrounds. The ⌬malB101 deletion removes all of the maltose transport genes, but GM1191 carries the pLH22 plasmid that supplies MalK. The pMY14 plasmid carrying malF515 and malG ϩ conferred the ability to utilize lactose as a sole carbon source in the GM1265 wild-type strain. This indicator strain carries a wild-type malF allele. Thus, the malF515 allele is dominant with respect to the Lac ϩ phenotype. However, the pMY14 plasmid, which supplies the only copies of malG and malF515, did not confer the ability to utilize lactose in the GM1191 ⌬malB101 deletion strain. Some component other than MalK and which is covered by the ⌬malB101 deletion, such as MBP or wild-type MalF, is required for a Lac ϩ phenotype.
To test the effect of MBP on the ability of the lactosespecificity mutant to utilize lactose, we used a plasmid (pNT7) that carries the malE gene under the control of the malB promoter on a low-copy-number plasmid. We found that the Lac ϩ phenotype of malF515 could be observed only in the presence of wild-type MBP. Therefore, the inability of pMY14 to confer a Lac ϩ phenotype to GM1191 must be due to the absence of MBP rather than a requirement for wild-type MalF.
In order to find out if MBP binds lactose and thus facilitates the transport of lactose across the cytoplasmic membrane via the mutant inner membrane complex, we measured the binding of lactose to purified MBP using two independent techniques. The first technique indirectly measures binding by assaying the decrease in intrinsic fluorescence of MBP in response to the binding of the substrate (47) . MBP undergoes a conformational change ("hinge-twist motion") upon binding the substrate that brings fluorescence-emitting tryptophan residues closer together, causing them to quench each other. No VOL. 179, 1997 UNLIGANDED MBP TRIGGERS LACTOSE TRANSPORT 7689 decrease in fluorescence was observed, even at 5 mM lactose (Fig. 1) . The second technique was to measure binding by assaying the rate of exit of [ 14 C]lactose from a dialysis bag containing a known amount of purified MBP (45) . Under the conditions that were used, a K d of binding as high as 1 mM could be detected. No binding was detected by this method either. We conclude that although MBP is required for lactose transport, its ability to bind lactose is undetectable by two independent sensitive methods.
The lactose-specificity mutant cannot transport lactose with MBP mutants defective in triggering. The fact that MBP is required for lactose transport, even though it is incapable of binding lactose, suggests that MBP is required for triggering the transport cycle. In order to test this idea, we took advantage of MBP mutants that have been shown to be defective in the triggering of transport. These mutants were isolated as suppressors of MBP-independent alleles of malF and malG (26, 49) . MBP-independent mutants are unable to transport maltose in the presence of wild-type levels of MBP. The single point mutations in each of these MBP mutants restores a productive interaction between only the suppressor MBP and its respective MBP-independent inner membrane complex but is unable to trigger transport via the wild-type complex. The mutations map to regions thought to come in direct contact with the inner membrane complex. The MBP mutants were shown to bind ligand with a K d comparable to that of wild-type MBP and retain the ability to interact with the inner membrane complex (26, 49) .
To determine if any of the mutant MBPs are capable of a productive interaction with either the wild-type or lactosespecificity mutant form of the MalFGK 2 inner membrane complex, we assayed the ability of a strain carrying wild-type malE or the various mutant malE alleles to utilize maltose or lactose as a sole carbon source. All experiments were conducted in the GM1418 strain background that has a Tn5 transposon in the chromosomal malE gene, which is polar on malF and malG and carries the malT(Con) allele (12), ensuring constitutive mal gene expression. This strain also has a deletion of the lac operon and carries the pAB1 plasmid that overproduces LacZ and allowed us to assess a lactose phenotype. The wild-type malF and malG genes were provided by plasmid pLH9, and the lactose-specificity allele malF515 and malG ϩ were provided by plasmid pMY14. Plasmid pTE18 supplied lactose permease and was used as a control.
As expected, wild-type MBP supported maltose transport by MalF515 and the wild-type MalFG control ( Table 2 ). The MBP mutants displayed a decreased ability to transport maltose, indicating a defect in the ability to trigger transport. Wild-type MBP supported lactose transport by MalF515, as expected. However, none of the triggering-defective mutant MBPs supported lactose transport by MalF515. This result suggests that the ability to trigger the transport cycle is essential for MBP to support the transport of lactose by MalF515.
Lactose transport via the MalF515 mutant requires MalK. To determine if the lactose-specificity mutant requires MalKATPase activity in order to transport lactose, we utilized a plasmid (pAS1) that carries the malK804 allele (34) . This allele has a mutation that causes a lysine-to-asparagine amino acid change at position 42 of MalK, rendering it unable to function as an ATPase but still allowing formation of a stable MalFGK 2 inner membrane complex (34) . As a positive control, we used a plasmid, pHS4, that carries the wild-type malK gene. The pMY14 plasmid was transformed into the lactose indicator 
a Utilization of maltose was scored as growth on M63 minimal medium containing 0.2% maltose, ampicillin, kanamycin, chloramphenicol, tetracycline, and 0.004% isoleucine, leucine, and valine after 2 days at 37°C in the GM1418 strain background.
b Utilization of lactose was scored as growth on M63 minimal medium containing 1% lactose, ampicillin, kanamycin, chloramphenicol, tetracycline, and 0.004% isoleucine, leucine, and valine after 2 days at 37°C in the GM1418 strain background.
c NA, not applicable.
strains GM1307 and GM1308. These strains have their maltose transport genes (⌬malB101) deleted, have MBP provided by the pNT7 plasmid, and carry either of the two malK plasmids (pHS4 and pAS1, respectively). The lactose-specificity mutant plasmid pMY14 conferred a Lac ϩ phenotype only on GM1307, indicating that lactose transport did not occur via complexes containing a defective MalK-ATPase.
Kinetics of maltose transport via MalF515. It has previously been shown that MalF515 (L334W) has lost the MBP-independent phenotype associated with MalF526 (L334W, N505I) and behaves like the wild type with respect to its requirement of MBP for the transport of maltose (7). We reached the same conclusion upon repetition of similar experiments (data not shown).
However, we compared the kinetics of maltose transport by MalF515 with that of the wild-type system by measuring the initial velocity of [
14 C]maltose uptake as a function of external substrate concentration (data not shown). The concentration which results in half-maximal velocity (K m ) is 1.2 M for the specificity mutant, which is very close to the K m of 1 M for wild-type maltose transport. However, the maximal velocity of maltose uptake (V max ) by the mutant of 18 pmol/min/10 8 cells, is considerably slower than the V max of 500 pmol/min/10 8 cells by the wild-type maltose transport system. Growth and lactose transport properties of the lactose-specificity mutant. To evaluate the ability of the lactose-specificity mutant to utilize lactose as a sole carbon and energy source, we measured the generation time of strain GM1305 carrying the pMY14 plasmid in M63 minimal lactose liquid medium. We also measured the ability of the mutant to actively transport [ 14 C]lactose (Table 3) .
The lactose-specificity mutant plasmid pMY14 conferred shorter doubling times in M63 minimal medium plus lactose than plasmid pTE18, which carries lacY. This suggests that the specificity mutant efficiently utilizes lactose. GM1305 carrying the wild-type maltose transport genes (malF and malG) on the pLH9 plasmid did not display a measurable doubling time.
We compared the kinetics of lactose transport by the lactose-specificity mutant with that of the lactose permease system by measuring the initial velocity of [
14 C]lactose uptake as a function of external substrate concentration. The values obtained from a double-reciprocal plot of the initial velocity of [ 14 C]lactose uptake versus the external concentration of lactose are shown in Table 3 . The maximal velocity of lactose uptake (V max ) conferred by the pMY14 plasmid is 80 pmol/ min/10 8 cells. This value is not as high as that observed with the lactose permease transport system (pTE18), 330 pmol/min/10 8 cells, but it does fall within a comparable range. The concentration which results in half-maximal velocity (K m ) is 1.3 mM for the strain carrying the lactose permease transport system (pTE18), while it is 2.0 mM for the pMY14 specificity mutant plasmid. The apparent contradiction that the doubling time for the strain carrying pTE18 is longer than that for the strain carrying pMY14, even though the former transports lactose more efficiently, may be explained by the fact that overproduction of LacY by the pTE18 plasmid might decrease the growth rate for reasons unrelated to transport activity.
To ensure that the ability of MalF515 to transport lactose is not due to the release of cytosolic ␤-galactosidase into the medium, we measured the levels of ␤-galactosidase in the medium of cells used for transport with the colorimetric reagent ortho-nitrophenyl-␤-D-galactopyranoside (ONPG). ␤-Galactosidase in the medium could metabolize the lactose to glucose, which might then be taken up by the phosphoenolpyruvate phosphotransferase system of the cell. All of the strains used in the transport experiments displayed the same low levels of ␤-galactosidase in the medium (data not shown), which are unlikely to account for the observed differences in the abilities of the strains to transport lactose.
Specificity of transport by the lactose-specificity mutant. We examined the specificity of lactose transport via MalF515 by evaluating the ability of different sugars to compete with [ 14 C]lactose uptake (Fig. 2) . A collection of 30 available monosaccharides, disaccharides, and trisaccharides was tested at 100 mM to see if any of the sugars inhibited the transport of 1 mM [
14 C]lactose (data not shown). Sugars that displayed the greatest inhibitory activity were then tested with 10 mM inhibitor (Fig. 2) . Only a small number of sugars strongly inhibited [ 14 C]lactose transport at the lower concentration. Those sugars which were tested for inhibitory activity at 100 mM but did not noticeably inhibit include methyl-glucopyranoside, arabinose, rhamnose, fructose, xylose, melibiose, raffinose, palatinose, cellobiose, gentiobiose, isomaltose, and fucose.
Glucose displayed the greatest inhibitory activity. Inhibition by glucose suggests that the lactose-specificity mutant recognizes the reducing moiety of the disaccharide lactose (␤1,4-glucose-galactoside). ONPG, a lactose analog that is used as a colorimetric reagent in assaying for the presence of ␤-galactosidase, inhibited [ 14 C]lactose transport considerably (Ͼ80% inhibition). Maltose and maltotriose also inhibited the transport of [ 14 C]lactose by Ͼ80%. This result is not surprising, since we have shown that MalF515 can transport [
14 C]maltose very efficiently.
The inhibition of lactose transport by glucose is unlikely due to the well-known effects of dephospho-IIA Glu of the PTS on maltose transport because methyl-glucopyranoside had no inhibitory effect yet is a more potent mediator of dephospho-IIA Glu -mediated inhibition. The transport of 0.5 M [ 14 C]maltose by MalF515 was only slightly inhibited by 200 mM lactose. This result is not entirely surprising, considering the much lower K m for maltose transport (1 M) compared to that for lactose transport (2 mM) ( Table 3) . It seems that the pathway utilizing maltose bound to MBP is preferred to that for lactose, which does not bind MBP.
Based on double-reciprocal plots (Fig. 3) , maltose acts as a competitive inhibitor on the transport of [ 14 C]lactose by MalF515. The apparent K i for maltose transport is about 80 M. This result suggests that both sugars use the same transport pathway.
The malF515 allele could not confer the ability to transport two sugars that inhibit lactose transport, namely, glucose and trehalose. No glucose transport was observed when the malF515 allele was introduced into two Glu Ϫ strains, PPA69 and UE44, as determined by growth on minimal-mediumglucose plates and red color development on MacConkey agarglucose plates (data not shown). PPA69 carries the ⌬pts(I-H) . No glucose transport was observed when the malF515 allele was introduced into a Tre Ϫ strain, Rho67, as determined by growth on minimal-medium-trehalose plates and red color development on MacConkey agar-trehalose plates (data not shown). Rho67 carries several alleles that render it Tre Ϫ . Furthermore, the malF515 allele on the pMY14 plasmid was unable to confer the ability to transport ONPG on the lactose indicator strain GM1305, as assayed by a colorimetric uptake assay on whole cells (data not shown). These results suggest that some of the sugars that inhibit the transport of [ 14 C]lactose by MalF515, namely, glucose, trehalose, and ONPG, are recognized but are not transported by the mutant complex.
DISCUSSION
Several lines of evidence suggest the presence of a substrate site in the inner membrane components of the maltose transport system. Recent developments in the study of the substrate sites of other members of the ABC superfamily of transporters has shed some light on this topic. Most notably, energy transfer experiments (37) , epitope mapping of proteolytic fragments, and cross-linking studies with substrates and substrate analogs of P-gp (5, 18, 32) have suggested that the transmembrane helices play an important role in the recognition of a substrate by ABC transporters. The genetic analysis of chimeric molecules constructed from different members of the P-gp family (52) , as well as the isolation and construction of discrete mutations in P-gp, points to the transmembrane helices being involved in substrate specificity (18) . In particular, many of the biochemical and genetic studies point to regions around transmembrane helices 5 to 6 and 11 to 12 as being important. Furthermore, the regions around transmembrane helices 5 and 11 have been found to show a high degree of sequence homology among members of the P-gp family of proteins as well as other select members of the ABC superfamily of transporters (18) .
Although the integral membrane components of the maltose transport system bear little sequence homology to the integral membrane portions of P-gp, it is interesting that the L334W lactose-specificity mutation is located in the same transmembrane helix, TM5, that has been implicated in many of the aforementioned studies as playing an important role in determining the substrate specificity of P-gp (35) . The fifth transmembrane helix of MalF displays a rather amphipathic character that is typical of helices thought to be involved in the formation of the path through which the substrate must travel. MBP is absolutely required for the transport of lactose by the MalF515 mutant maltose system. Since MBP does not bind lactose (Fig. 1) , unloaded MBP facilitates transport by some other means. A similar observation has been made in the wild-type ProU transport system, where the binding protein is necessary for the transport of the osmoprotectant pipecolic acid, although it does not bind pipecolic acid (17) . These results also support results of previous experiments where it has been shown that both the substrate-loaded and unloaded forms of MBP interact with the wild-type inner membrane complex (29) .
The possibility that MBP is required solely for the triggering of the transport process was further probed by using a collection of MBP mutants (Table 2) . It is clear from our experiments that some property of MBP other than the ability to bind the substrate or dock onto the inner membrane complex is critical to the transport of lactose by the mutant system. Perhaps this property is the ability of MBP to trigger the transport and ATPase activities of the system. As has been previously reported by Davidson et al., unliganded MBP exhibits a low but measurable ability to trigger ATP hydrolysis (9, 10) .
A recent study of the histidine transport system of E. coli (1), which is also a periplasmic-binding-protein-dependent ABC transporter, supports our conclusion that both the liganded and unliganded forms of the periplasmic binding protein interact with the inner membrane complex (29) . Using chemical cross-linking and cosedimentation procedures, those researchers showed that the unliganded form of the histidine-binding protein (HisJ) interacts with the inner membrane complex with an affinity comparable to that of liganded HisJ. Furthermore, they observe that unliganded HisJ triggers the ATPase activity of the system. This result agrees with our observation that the triggering capability of unliganded binding protein is the essential component in facilitating lactose transport by the MalF515 mutant.
We observed that the K i for maltose inhibition of lactose transport by MalF515 is 80 M but that the K m for maltose transport by the mutant is 1.2 M. For a simple transport system, the K i of a given competitive inhibitor that is also a substrate for transport usually closely approximates the K m for the transport of that substrate (33) . However, for some experimental systems the two values have not been found to agree, suggesting that the simple model does not always apply (33) . Furthermore, this particular case is complicated by the fact that the transport of lactose and maltose by MalF515 are both dependent on the presence of MBP and it is unclear what the consequences on lactose transport are of having liganded MBP present. It is a formal possibility that liganded MBP influences the rate of lactose transport by this mutant.
It is interesting to speculate why unliganded MBP interacts with the inner membrane complex. The observations presented here as well as those of our earlier study (29) and the studies by other labs of the histidine transport system (1) indicate that unliganded binding protein interacts with the inner membrane complex and triggers ATPase activity. One possibility is that the stimulation of ATP hydrolysis by unliganded binding protein converts the inner membrane complex to an "open" state primed for transport, thus providing the periplasmic substrate access to the substrate site of the inner membrane complex.
There is also the possibility that the maltose transport system contains two figurative paths for the transport of substrate. One path is dependent on substrate being bound to MBP and delivered to the inner membrane complex, where the transport cycle is triggered, resulting in ATP hydrolysis and translocation of the substrate across the inner membrane. This path would display a high affinity (K m in micromolar units). The alternative path would involve substrate binding to the inner membrane complex independent of MBP, but it would still require unliganded and/or liganded MBP to interact with the inner membrane complex and trigger the transport cycle. This alternative path would display a lower affinity (K m in millimolar units). This suggestion helps to explain the existence of MBP-independent mutants that display constitutive ATPase activities, transport the substrate in the absence of MBP, and display similar K m values of approximately 1 mM. The substrates in these mutants access only the second path for transport and do not require MBP due to the constitutive ATPase activity of the mutant system. The lactose-specificity mutant MalF515, which displays a K m of 2 mM, also fits this model. The substrate, in this case, can access only the second low-affinity path, since MBP cannot bind the substrate lactose, but it still requires MBP to trigger ATPase activity and subsequent translocation of the substrate.
As mentioned in the introduction, we isolated another mutant of MalF that transports lactose. The MalF540 mutant contains an amber mutation that terminates translation after the third transmembrane helix of MalF and does not require MBP. However, the MalF540 mutant displays constitutive ATPase activity, suggesting that the necessity for MBP to trigger the transport cycle is circumvented. The fact that this mutant can transport lactose in a specific manner indicates that there may be several ways to alter the substrate specificities of transport proteins by modifying the structures of transmembrane segments.
